Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes

George J Dover, S. H. Boyer, W. H. Zinkham

Research output: Contribution to journalArticle

Abstract

Serial microscopic immunodiffusion assays of F cells, i.e., erythrocytes that contain fetal hemoglobin (HbF), in four individuals recovering from anemia demonstrate initial increases in the percentage of circulating reticulocytes that contain HbF (F reticulocytes) and subsequent increases in the percentage of mature erythrocytes that contain HbF (F erythrocytes). In one individual responding to therapy for iron-deficiency anemia, the average percentage of F reticulocytes increased from 4.8 ± 1.1 to 16.0 ± 2.8% (mean ± SD), while the mean level of F erythrocytes increased from 3.5 ± 0.7 to 7.2 ± 0.6%. Two normal children with transient erythroblastopenia exhibited F reticulocyte percentages of 71.3 ± 6.7 and 41.5 ± 1.5%, respectively, when erythropoiesis resumed. With recovery these values fell to finally measured values of 33.7 ± 4.7 and 12.6 ± 1.1%, respectively. In an adolescent with sickle cell anemia, F-reticulocyte percentages fluctuated between 0.6 ± 1.1 and 34.0 ± 2.8% and paralleled the rise and fall of total reticulocytes associated with therapy for a nasopharyngeal carcinoma. Such findings suggest that first, the production of F cells and non-F cells are separately regulated. Second, F-cell production is preferentially stimulated during escape from erythropoietic suppression and selectively depressed at the start of suppression. Third, during escape from erythropoietic suppression, F-cell production in vivo resembles that reported for in vitro cultures of erythroid stem cells. Fourth, individuals with sickle cell anemia, like individuals without hemoglobinopathies, can change their relative level of F-cell production.

Original languageEnglish (US)
Pages (from-to)173-176
Number of pages4
JournalJournal of Clinical Investigation
Volume63
Issue number2
StatePublished - 1979

Fingerprint

Fetal Hemoglobin
Reticulocytes
Anemia
Erythrocytes
Sickle Cell Anemia
Hemoglobinopathies
Erythroid Precursor Cells
Iron-Deficiency Anemias
Erythropoiesis
Immunodiffusion
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes. / Dover, George J; Boyer, S. H.; Zinkham, W. H.

In: Journal of Clinical Investigation, Vol. 63, No. 2, 1979, p. 173-176.

Research output: Contribution to journalArticle

@article{3acf45ed80b843ab8cc150441916dbe2,
title = "Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes",
abstract = "Serial microscopic immunodiffusion assays of F cells, i.e., erythrocytes that contain fetal hemoglobin (HbF), in four individuals recovering from anemia demonstrate initial increases in the percentage of circulating reticulocytes that contain HbF (F reticulocytes) and subsequent increases in the percentage of mature erythrocytes that contain HbF (F erythrocytes). In one individual responding to therapy for iron-deficiency anemia, the average percentage of F reticulocytes increased from 4.8 ± 1.1 to 16.0 ± 2.8{\%} (mean ± SD), while the mean level of F erythrocytes increased from 3.5 ± 0.7 to 7.2 ± 0.6{\%}. Two normal children with transient erythroblastopenia exhibited F reticulocyte percentages of 71.3 ± 6.7 and 41.5 ± 1.5{\%}, respectively, when erythropoiesis resumed. With recovery these values fell to finally measured values of 33.7 ± 4.7 and 12.6 ± 1.1{\%}, respectively. In an adolescent with sickle cell anemia, F-reticulocyte percentages fluctuated between 0.6 ± 1.1 and 34.0 ± 2.8{\%} and paralleled the rise and fall of total reticulocytes associated with therapy for a nasopharyngeal carcinoma. Such findings suggest that first, the production of F cells and non-F cells are separately regulated. Second, F-cell production is preferentially stimulated during escape from erythropoietic suppression and selectively depressed at the start of suppression. Third, during escape from erythropoietic suppression, F-cell production in vivo resembles that reported for in vitro cultures of erythroid stem cells. Fourth, individuals with sickle cell anemia, like individuals without hemoglobinopathies, can change their relative level of F-cell production.",
author = "Dover, {George J} and Boyer, {S. H.} and Zinkham, {W. H.}",
year = "1979",
language = "English (US)",
volume = "63",
pages = "173--176",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes

AU - Dover, George J

AU - Boyer, S. H.

AU - Zinkham, W. H.

PY - 1979

Y1 - 1979

N2 - Serial microscopic immunodiffusion assays of F cells, i.e., erythrocytes that contain fetal hemoglobin (HbF), in four individuals recovering from anemia demonstrate initial increases in the percentage of circulating reticulocytes that contain HbF (F reticulocytes) and subsequent increases in the percentage of mature erythrocytes that contain HbF (F erythrocytes). In one individual responding to therapy for iron-deficiency anemia, the average percentage of F reticulocytes increased from 4.8 ± 1.1 to 16.0 ± 2.8% (mean ± SD), while the mean level of F erythrocytes increased from 3.5 ± 0.7 to 7.2 ± 0.6%. Two normal children with transient erythroblastopenia exhibited F reticulocyte percentages of 71.3 ± 6.7 and 41.5 ± 1.5%, respectively, when erythropoiesis resumed. With recovery these values fell to finally measured values of 33.7 ± 4.7 and 12.6 ± 1.1%, respectively. In an adolescent with sickle cell anemia, F-reticulocyte percentages fluctuated between 0.6 ± 1.1 and 34.0 ± 2.8% and paralleled the rise and fall of total reticulocytes associated with therapy for a nasopharyngeal carcinoma. Such findings suggest that first, the production of F cells and non-F cells are separately regulated. Second, F-cell production is preferentially stimulated during escape from erythropoietic suppression and selectively depressed at the start of suppression. Third, during escape from erythropoietic suppression, F-cell production in vivo resembles that reported for in vitro cultures of erythroid stem cells. Fourth, individuals with sickle cell anemia, like individuals without hemoglobinopathies, can change their relative level of F-cell production.

AB - Serial microscopic immunodiffusion assays of F cells, i.e., erythrocytes that contain fetal hemoglobin (HbF), in four individuals recovering from anemia demonstrate initial increases in the percentage of circulating reticulocytes that contain HbF (F reticulocytes) and subsequent increases in the percentage of mature erythrocytes that contain HbF (F erythrocytes). In one individual responding to therapy for iron-deficiency anemia, the average percentage of F reticulocytes increased from 4.8 ± 1.1 to 16.0 ± 2.8% (mean ± SD), while the mean level of F erythrocytes increased from 3.5 ± 0.7 to 7.2 ± 0.6%. Two normal children with transient erythroblastopenia exhibited F reticulocyte percentages of 71.3 ± 6.7 and 41.5 ± 1.5%, respectively, when erythropoiesis resumed. With recovery these values fell to finally measured values of 33.7 ± 4.7 and 12.6 ± 1.1%, respectively. In an adolescent with sickle cell anemia, F-reticulocyte percentages fluctuated between 0.6 ± 1.1 and 34.0 ± 2.8% and paralleled the rise and fall of total reticulocytes associated with therapy for a nasopharyngeal carcinoma. Such findings suggest that first, the production of F cells and non-F cells are separately regulated. Second, F-cell production is preferentially stimulated during escape from erythropoietic suppression and selectively depressed at the start of suppression. Third, during escape from erythropoietic suppression, F-cell production in vivo resembles that reported for in vitro cultures of erythroid stem cells. Fourth, individuals with sickle cell anemia, like individuals without hemoglobinopathies, can change their relative level of F-cell production.

UR - http://www.scopus.com/inward/record.url?scp=0018377771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018377771&partnerID=8YFLogxK

M3 - Article

C2 - 429549

AN - SCOPUS:0018377771

VL - 63

SP - 173

EP - 176

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -